A new report issued by the Copenhagen based iris group for investment in Odense, an investment promotion agency, points out that Danish medical marijuana companies have attracted more than DKK 1.5 billion (US $217 million) of external capital, including the founders' own investment, with an average investment of US $6 million per company. The largest investment came from founders and employees, who invested US $96.5 million, accounting for 44% of the investment. The analysis shows that the European medical marijuana market is developing towards a more pharmaceutical product development and distribution mode, rather than the common pharmacy retail mode in North America. "Most of the growth in the European medical marijuana industry will come from the sale of extracts and isolates, not dried flowers." It is estimated that in 2023, the sales of fried dough twist may decline to slightly less than 45% of the total sales.
Source: mjbizdaily com/